Robert Tan

Robert Tan is an Assistant Professor in the Department of Pharmacy Practice at the School of Pharmacy, Loma Linda University. He holds a PharmD degree awarded in June 1998. His research focuses on optimizing immunosuppression regimens in pediatric heart transplant recipients, particularly exploring calcineurin inhibitor minimization, corticosteroid-free protocols, and targeted therapies like rituximab for managing complications such as EBV viremia and PTLD. His work also evaluates drug efficacy comparisons between sirolimus and everolimus in pediatric transplant populations.

Key research contributions include studies published between 2016 and 2020 in journals like the Journal of Heart and Lung Transplantation and Pediatric Transplantation. His articles highlight advancements in reducing immunosuppressive toxicity while maintaining graft survival, with a focus on pediatric-specific challenges. Despite no explicitly listed awards or grants, his peer-reviewed publications reflect active engagement in clinical pharmacotherapy research within transplant medicine.

No affiliated laboratories, teams, or advisee students are explicitly documented in the provided texts.